Abiopharma

🔍 MAROONE MICHAEL E (Director)

Company: CARVANA CO. (CVNA)

Report Date: 2026-04-14

Detailed Transactions and Holdings:

• Acquired 454 shares of Class A Common Stock (Direct)
  Date: 2026-04-14 | Code: A | equity_swap_involved: 0 | shares_owned_after: 144,027.00 | transaction_form_type: 4 | Footnotes: F1, F1
• Acquired 782 shares of Class A Common Stock (Direct)
  Date: 2026-04-14 | Code: A | equity_swap_involved: 0 | shares_owned_after: 144,809.00 | transaction_form_type: 4 | Footnotes: F2, F2
• Holds 0 shares of Class A Common Stock (Direct)
  Date: 2026-04-14 | Code: H | nature_of_ownership: By Michael Maroone Family Partnership, LP | shares_owned_after: 45,000.00 | Footnotes: F3
• Holds 0 shares of Class A Common Stock (Direct)
  Date: 2026-04-14 | Code: H | nature_of_ownership: By Family Trust FBO Michael E. Maroone | shares_owned_after: 264.00 | Footnotes: F4

Footnotes:

• F1: Represents shares of Class A Common Stock of Carvana Co. (the "Issuer") underlying restricted stock units acquired by the Reporting Person. 100% of the restricted stock units vest immediately on grant.
• F2: Represents shares of Class A Common Stock of the Issuer underlying restricted stock units acquired by the Reporting Person. The restricted stock units vest 100% on May 1, 2027, subject to the Reporting Person's continued service with the Issuer as of such date.
• F3: Represents shares of Class A common stock held directly by the Michael Maroone Family Partnership, LP, an entity controlled by the Reporting Person.
• F4: Represents shares of Class A common stock held directly by the Family Trust FBO Michael E. Maroone, where the Reporting Person is beneficiary and trustee.